BD Diagnostics, Diagenode to Co-develop Assays on BD Max System

The companies will co-develop seven assays for pathogens associated with respiratory, enteric, and central nervous system diseases.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories